{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:37Z","timestamp":1793327317913,"version":"4.5.0"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1070,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Australasian Journal of Dermatology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/j.1440-0960.2012.00947.x","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T16:53:38Z","timestamp":1348764818000},"page":"157-162","source":"Crossref","is-referenced-by-count":98,"title":["Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?"],"prefix":"10.1111","volume":"54","author":[{"given":"Marius","family":"Rademaker","sequence":"first","affiliation":[{"name":"Dermatology Department; Waikato Hospital; Hamilton; New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,26]]},"reference":[{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0001|ajd947-cit-0001","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0190-9622(08)80252-6","article-title":"Guidelines for optimal use of isotretinoin in acne","volume":"27","author":"Layton","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0002|ajd947-cit-0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM197902153000701","article-title":"Prolonged remissions of cystic and conglobata acne with 13-cis-retinoic acid","volume":"300","author":"Peck","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0003|ajd947-cit-0003","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0190-9622(80)80074-0","article-title":"The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial","volume":"3","author":"Farrell","year":"1980","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0004|ajd947-cit-0004","first-page":"634","article-title":"13-cis retinoic acid in the oral therapy of acne conglobata. Results of a multi-center study","volume":"32","author":"Plewig","year":"1981","journal-title":"Hautarzt"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0005|ajd947-cit-0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(82)80055-8","article-title":"Changes in long-term sebum production from isotretinoin therapy","volume":"6","author":"Strauss","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0006|ajd947-cit-0006","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(82)70063-5","article-title":"Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study","volume":"6","author":"Peck","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0007|ajd947-cit-0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1983.tb03973.x","article-title":"A dose-response study of I3-cis-retinoic acid in acne vulgaris","volume":"108","author":"Jones","year":"1983","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0008|ajd947-cit-0008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2133.1984.tb04707.x","article-title":"Effect of low dose cyproterone acetate on the response of acne to isotretinoin","volume":"110","author":"Marsden","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0009|ajd947-cit-0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.1984.tb04030.x","article-title":"Remission rates in acne patients treated with various doses of 13-cis-retinoic acid (isotretinoin)","volume":"111","author":"Jones","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0010|ajd947-cit-0010","first-page":"203","volume-title":"Acne and Related Disorders","author":"Harms","year":"1989"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0011|ajd947-cit-0011","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000246134","article-title":"Roaccutane treatment guidelines: results of an international survey","volume":"194","author":"Cunliffe","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0012|ajd947-cit-0012","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J. Immunol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0013|ajd947-cit-0013","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.0022-202x.2001.01569.x","article-title":"Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions","volume":"117","author":"Chronnell","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0014|ajd947-cit-0014","volume-title":"Dermatology","author":"Kuenzli","year":"2008"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0015|ajd947-cit-0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0016|ajd947-cit-0016","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/jid.2008.338","article-title":"Isotretinoin temporally regulates distinct sets of genes in patient skin","volume":"129","author":"Nelson","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0017|ajd947-cit-0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/derm.1.3.8258","article-title":"Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action","volume":"1","author":"Nelson","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0018|ajd947-cit-0018","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","article-title":"Adverse effects of isotretinoin. A retrospective study of 1743 patients","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0019|ajd947-cit-0019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a multicenter dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0020|ajd947-cit-0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1439-0353.2004.03739.x","article-title":"Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne","volume":"2","author":"Plewig","year":"2004","journal-title":"J. Dtsch Dermatol. Ges."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0021|ajd947-cit-0021","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1365-2303.2003.00108.x-i1","article-title":"Very low dose isotretinoin is effective in controlling seborrhea","volume":"1","author":"Geissler","year":"2003","journal-title":"J. Dtsch Dermatol. Ges."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0022|ajd947-cit-0022","doi-asserted-by":"crossref","unstructured":"Rademaker M Wishart J Birchall N Isotretinoin 5 mg daily for persistent low-grade adult acne vulgaris - a randomised double blind study 2012","DOI":"10.1111\/jdv.12170"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0023|ajd947-cit-0023","first-page":"224","article-title":"Acne flares and deteriorations during oral isotretinoin therapy","volume":"128","author":"Chivot","year":"2001","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0024|ajd947-cit-0024","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000182270","article-title":"Acute acne flare following isotretinoin administration: potential protective role of low starting dose","volume":"218","author":"Borghi","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0025|ajd947-cit-0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000248038","article-title":"Isotretinoin and acne - a study of relapses","volume":"180","author":"Chivot","year":"1990","journal-title":"Dermatologica"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0026|ajd947-cit-0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000247322","article-title":"Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years","volume":"186","author":"Lehucher-Ceyrac","year":"1993","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0027|ajd947-cit-0027","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","article-title":"Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin","volume":"212","author":"Quereux","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0028|ajd947-cit-0028","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-4362.1994.tb01500.x","article-title":"Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore","volume":"33","author":"Shahidullah","year":"1994","journal-title":"Int. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0029|ajd947-cit-0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1993.tb11850.x","article-title":"Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?","volume":"129","author":"Stainforth","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0030|ajd947-cit-0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000090646","article-title":"The truth behind this undeniable efficacy - recurrence rates and relapse risk factors of acne treatment with oral isotretinoin","volume":"212","author":"Zouboulis","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0031|ajd947-cit-0031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/000155557374","article-title":"Severe flares of acne following isotretinoin: large closed comedones (macrocomedones) are a risk factor","volume":"73","author":"Bottomley","year":"1993","journal-title":"Acta Derm. Venereol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0032|ajd947-cit-0032","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1997.tb03710.x","article-title":"Treatment of acne with intermittent isotretinoin","volume":"137","author":"Goulden","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0033|ajd947-cit-0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000249320","article-title":"The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study","volume":"172","author":"Harms","year":"1986","journal-title":"Dermatologica"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0034|ajd947-cit-0034","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018130","article-title":"Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients","volume":"198","author":"Lehucher-Ceyrac","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0035|ajd947-cit-0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00128071-200809050-00001","article-title":"Global alliance to improve outcomes in acne. Can we define acne as a chronic disease? If so, how and when?","volume":"9","author":"Gollnick","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"issue":"5","key":"10.1111\/j.1440-0960.2012.00947.x-BIB0036|ajd947-cit-0036","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/0190-9622(95)90414-X","article-title":"Acne: acute or chronic disease?","volume":"32","author":"Thiboutot","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0037|ajd947-cit-0037","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/jwh.2010.2722","article-title":"Acne vulgaris in women: prevalence across the life span","volume":"21","author":"Perkins","year":"2012","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0038|ajd947-cit-0038","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","article-title":"An epidemiological study of acne in female adults: results of a survey conducted in France","volume":"15","author":"Poli","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0039|ajd947-cit-0039","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2133.1998.02321.x","article-title":"Acne vulgaris in the elderly: the response to low-dose isotretinoin","volume":"139","author":"Seukeran","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0040|ajd947-cit-0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2133.2000.03626.x","article-title":"\u2018Microdose\u2019 isotretinoin","volume":"143","author":"Palmer","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0041|ajd947-cit-0041","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00128071-200607050-00002","article-title":"Persistent acne in women: implications for the patient and for therapy","volume":"7","author":"Williams","year":"2006","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0042|ajd947-cit-0042","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1529-8019.2006.00084.x","article-title":"Update in retinoid therapy of acne","volume":"19","author":"Thielitz","year":"2006","journal-title":"Dermatol. Ther."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0043|ajd947-cit-0043","first-page":"817","article-title":"Use of systemic retinoids in dermatology","volume":"95","author":"Fritsch","year":"1983","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0044|ajd947-cit-0044","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/edm.10.58","article-title":"Oral isotretinoin: the most promising dermatological off-label uses","volume":"5","author":"Bagatin","year":"2010","journal-title":"Expert Rev. Dermatol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0045|ajd947-cit-0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1524-4725.2000.99210.x","article-title":"Oral isotretinoin as part of the treatment of cutaneous aging","volume":"26","author":"Hernandez-Perez","year":"2000","journal-title":"Dermatol. Surg."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0046|ajd947-cit-0046","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1540-9740.2007.07145.x","article-title":"Use of oral isotretinoin in photoaging therapy","volume":"7","author":"Kalil","year":"2008","journal-title":"Skinmed"},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0047|ajd947-cit-0047","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1468-3083.2008.02947.x","article-title":"Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication","volume":"23","author":"Rabello-Fonseca","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1111\/j.1440-0960.2012.00947.x-BIB0048|ajd947-cit-0048","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-4632.2009.04310.x","article-title":"A randomized and controlled trial about the use of oral isotretinoin for photoaging","volume":"49","author":"Bagatin","year":"2010","journal-title":"Int. J. Dermatol."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2012.00947.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1440-0960.2012.00947.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T21:18:43Z","timestamp":1714425523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2012.00947.x"}},"subtitle":["Isotretinoin: dose, duration, relapse"],"short-title":[],"issued":{"date-parts":[[2012,9,26]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2012.00947.x","relation":{},"ISSN":["0004-8380"],"issn-type":[{"value":"0004-8380","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,26]]}}}